Research progress on intestinal flora and renal transplantation

Qin Hao; Zhang Jian; Lin Jun

doi:10.3969/j.issn.1674-7445.2020.04.016

Volume 11 Issue 4

Jul. 2020

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2020 > 11(4): 516-520, 532

Qin Hao, Zhang Jian, Lin Jun. Research progress on intestinal flora and renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016

Citation:

Qin Hao, Zhang Jian, Lin Jun. Research progress on intestinal flora and renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016

Citation:

Qin Hao, Zhang Jian, Lin Jun. Research progress on intestinal flora and renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016

PDF( 812 KB)

Research progress on intestinal flora and renal transplantation

doi: 10.3969/j.issn.1674-7445.2020.04.016

Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

More Information

Corresponding author: Lin Jun, Email: 13601355682@163.com
Received Date: 2020-04-11
Available Online: 2021-01-19
Publish Date: 2020-07-15

Abstract

Abstract

In recent years, with the gradual improvement of people's understanding of intestinal flora, exploring common complications after renal transplantation from the perspective of intestinal flora has become a research hotspot. Studies have demonstrated that the composition of the intestinal flora in renal transplant recipients has significant differences before and after surgery, and this difference is closely related to the occurrence and development of many complications after renal transplantation such as infection, rejection, diarrhea and so on, which could affect the prognosis of the recipients. This article reviewed the research progress on intestinal flora and renal transplantation in order to provide new treatment ideas and strategies for renal transplant recipients.
- Renal transplantation,
- Intestinal flora,
- Infection,
- Rejection,
- Diarrhea,
- Immunosuppressant,
- Fecal bacteria transplantation,
- Microecologics

FullText(HTML)

References(32)

References

[1]	OPAZO MC, ORTEGA-ROCHA EM, CORONADO-ARRÁZOLA I, et al. Intestinal microbiota influences non-intestinal related autoimmune diseases[J]. Front Microbiol, 2018, 9:432. DOI: 10.3389/fmicb.2018.00432.
[2]	LING Y, WATANABE Y, OKUDA S. The human gut microbiome is structured to optimize molecular interaction networks[J]. Comput Struct Biotechnol J, 2019, 17:1040-1046. DOI: 10.1016/j.csbj.2019.07.011.
[3]	CREMONESI E, GOVERNA V, GARZON JFG, et al. Gut microbiota modulate T cell trafficking into human colorectal cancer[J]. Gut, 2018, 67(11):1984-1994. DOI: 10.1136/gutjnl-2016-313498.
[4]	GRAINGER J, DAW R, WEMYSS K. Systemic instruction of cell-mediated immunity by the intestinal microbiome[J]. F1000Res, 2018, 7: F1000 Faculty Rev-1910. DOI: 10.12688/f1000research.14633.1.
[5]	HUANG SH, CHEN YH, KONG G, et al. A novel genetic island of meningitic escherichia coli K1 containing the ibeA invasion gene (GimA): functional annotation and carbon-source-regulated invasion of human brain microvascular endothelial cells[J]. Funct Integr Genomics, 2001, 1(5):312-322. doi: 10.1007/s101420100039
[6]	CHENG HY, NING MX, CHEN DK, et al. Interactions between the gut microbiota and the host innate immune response against pathogens[J]. Front Immunol, 2019, 10:607. DOI: 10.3389/fimmu.2019.00607.
[7]	叶桂荣, 周敏捷, 于立新, 等.肾移植受者、慢性肾脏病患者和健康对照者肠道菌群的对比[J].南方医科大学学报, 2018, 38(12):1401-1408. DOI:10.12122/j.issn. 1673-4254.2018.12.01. YE GR, ZHOU MJ, YU LX, et al. Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects[J]. J South Med Univ, 2018, 38(12):1401-1408. DOI: 10.12122/j.issn.1673-4254.2018.12.01.
[8]	LEE JR, MUTHUKUMAR T, DADHANIA D, et al.Gut microbiota and tacrolimus dosing in kidney transplantation[J]. PLoS One, 2015, 10(3):e0122399. DOI: 10.1371/journal.pone.0122399.
[9]	KINNUNEN S, KARHAPÄÄ P, JUUTILAINEN A, et al. Secular trends in infection-related mortality after kidney transplantation[J]. Clin J Am Soc Nephrol, 2018, 13(5):755-762. DOI: 10.2215/CJN.11511017.
[10]	QI XZ, TU X, ZHA JW, et al. Immunosuppression-induced alterations in fish gut microbiota may increase the susceptibility to pathogens[J]. Fish Shellfish Immunol, 2019, 88:540-545. DOI: 10.1016/j.fsi.2019.03.035.
[11]	SWARTE JC, DOUWES RM, HU S, et al. Characteristics and dysbiosis of the gut microbiome in renal transplant recipients[J]. J Clin Med, 2020, 9(2): E386. DOI: 10.3390/jcm9020386.
[12]	CHAN S, ISBEL NM, HAWLEY CM, et al. Infectious complications following kidney transplantation-a focus on hepatitis C infection, cytomegalovirus infection and novel developments in the gut microbiota[J]. Medicina (Kaunas), 2019, 55(10): E672. DOI: 10.3390/medicina55100672.
[13]	LEI YM, CHEN L, WANG Y, et al. The composition of the microbiota modulates allograft rejection[J]. J Clin Invest, 2016, 126(7):2736-2744. DOI: 10.1172/JCI85295.
[14]	SEPULVEDA M, PIROZZOLO I, ALEGRE ML. Impact of the microbiota on solid organ transplant rejection[J]. Curr Opin Organ Transplant, 2019, 24(6):679-686. DOI: 10.1097/MOT.0000000000000702.
[15]	FRICKE WF, MADDOX C, SONG Y, et al. Human microbiota characterization in the course of renal transplantation[J]. Am J Transplant, 2014, 14(2):416-427. DOI: 10.1111/ajt.12588.
[16]	MCINTOSH CM, CHEN L, SHAIBER A, et al. Gut microbes contribute to variation in solid organ transplant outcomes in mice[J]. Microbiome, 2018, 6(1):96. DOI: 10.1186/s40168-018-0474-8.
[17]	陈益荣, 程光, 范明齐, 等.肾移植排斥患者肠道菌群变化的研究[J].中国微生态学杂志, 2014, 26(12):1421-1424. DOI: 10.13381/j.cnki.cjm.201412016. CHEN YR, CHENG G, FAN MQ, et al. Changes in the intestinal flora of patients with kidney transplant rejection[J]. Chin J Microecology, 2014, 26(12):1421-1424. DOI: 10.13381/j.cnki.cjm.201412016.
[18]	ZAZA G, DALLA GASSA A, FELIS G, et al. Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: comparison between an everolimus- and a standard tacrolimus-based regimen[J]. PLoS One, 2017, 12(5):e0178228. DOI: 10. 1371/journal.pone.0178228.
[19]	FLANNIGAN KL, TAYLOR MR, PEREIRA SK, et al. An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil[J]. J Heart Lung Transplant, 2018, 37(9):1047-1059. DOI: 10.1016/j.healun.2018.05.002.
[20]	TIELEMANS MM, VAN BOEKEL GAJ, VAN GELDER T, et al. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients[J]. Transplant Rev (Orlando), 2019, 33(2):55-63. DOI: 10.1016/j.trre.2018. 11.001.
[21]	JIA J, TIAN X, JIANG J, et al. Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation[J]. Front Med, 2019, 13(4):451-460. DOI: 10.1007/s11684-018-0675-3.
[22]	ZHANG L, DONG D, JIANG C, et al. Insight into alteration of gut microbiota in clostridium difficile infection and asymptomatic C. difficile colonization[J]. Anaerobe, 2015, 34:1-7. DOI: 10.1016/j.anaerobe.2015.03.008.
[23]	GU S, CHEN Y, ZHANG X, et al. Identification of key taxa that favor intestinal colonization of clostridium difficile in an adult Chinese population[J]. Microbes Infect, 2016, 18(1):30-38. DOI: 10.1016/j.micinf.2015.09.008.
[24]	ZHAO J, NIAN L, KWOK LY, et al. Reduction in fecal microbiota diversity and short-chain fatty acid producers in methicillin-resistant staphylococcus aureus infected individuals as revealed by PacBio single molecule, real-time sequencing technology[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(8):1463-1472. DOI: 10.1007/s10096-017-2955-2.
[25]	DINLEYICI EC, MARTÍNEZ-MARTÍNEZ D, KARA A, et al. Time series analysis of the microbiota of children suffering from acute infectious diarrhea and their recovery after treatment[J]. Front Microbiol, 2018, 9:1230. DOI: 10.3389/fmicb.2018.01230.
[26]	DERY KJ, KADONO K, HIRAO H, et al. Microbiota in organ transplantation: an immunological and therapeutic conundrum?[J]. Cell Immunol, 2020, 351:104080. DOI: 10.1016/j.cellimm.2020.104080.
[27]	LOPETUSO LR, SCALDAFERRI F, PETITO V, et al. Commensal clostridia: leading players in the maintenance of gut homeostasis[J]. Gut Pathog, 2013, 5(1):23. DOI: 10.1186/1757-4749-5-23.
[28]	LEE JR, MAGRUDER M, ZHANG L, et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients[J]. Am J Transplant, 2019, 19(2):488-500. DOI: 10.1111/ajt.14974.
[29]	TAYLOR MR, FLANNIGAN KL, RAHIM H, et al. Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity[J]. Sci Adv, 2019, 5(8):eaax2358. DOI: 10.1126/sciadv.aax2358.
[30]	王丹丹, 宋佳, 张晓岚.肠道菌群在肝脏疾病中的作用[J].临床肝胆病杂志, 2019, 35(9):2120-2123. DOI:10. 3969/j.issn.1001-5256.2019.09.053. WANG DD, SONG J, ZHANG XL. Research advances in the role of gut microbiota in liver diseases[J]. J ClinHepatol, 2019, 35(9):2120-2123. DOI:10.3969/j.issn.1001-5256. 2019.09.053.
[31]	KIM D, ZENG MY, NÚÑEZ G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases[J]. Exp Mol Med, 2017, 49(5):e339. DOI: 10.1038/emm.2017.24.
[32]	PANCHAL P, BUDREE S, SCHEELER A, et al. Scaling safe access to fecal microbiota transplantation: past, present, and future[J]. Curr Gastroenterol Rep, 2018, 20(4):14. DOI: 10.1007/s11894-018-0619-8.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (331) PDF downloads(46)

Research progress on intestinal flora and renal transplantation

doi: 10.3969/j.issn.1674-7445.2020.04.016

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research progress on intestinal flora and renal transplantation

doi: 10.3969/j.issn.1674-7445.2020.04.016

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content